NO20074037L - Farmasoytiske formuleringer med vedvarende frigivelse - Google Patents
Farmasoytiske formuleringer med vedvarende frigivelseInfo
- Publication number
- NO20074037L NO20074037L NO20074037A NO20074037A NO20074037L NO 20074037 L NO20074037 L NO 20074037L NO 20074037 A NO20074037 A NO 20074037A NO 20074037 A NO20074037 A NO 20074037A NO 20074037 L NO20074037 L NO 20074037L
- Authority
- NO
- Norway
- Prior art keywords
- sustained
- pharmaceutical formulations
- release pharmaceutical
- release
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64216805P | 2005-01-06 | 2005-01-06 | |
PCT/US2006/000503 WO2006074398A2 (en) | 2005-01-06 | 2006-01-05 | Sustained release pharmaceutical formulations comprising ranolazine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074037L true NO20074037L (no) | 2007-08-03 |
Family
ID=36648222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074037A NO20074037L (no) | 2005-01-06 | 2007-08-03 | Farmasoytiske formuleringer med vedvarende frigivelse |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060177502A1 (ko) |
EP (1) | EP1841411A2 (ko) |
JP (1) | JP2008526879A (ko) |
KR (1) | KR20070093988A (ko) |
CN (1) | CN101098682A (ko) |
AU (1) | AU2006203890A1 (ko) |
BR (1) | BRPI0606403A2 (ko) |
CA (1) | CA2593593A1 (ko) |
GE (1) | GEP20094784B (ko) |
IL (1) | IL184460A0 (ko) |
MX (1) | MX2007008162A (ko) |
NO (1) | NO20074037L (ko) |
RU (1) | RU2384332C2 (ko) |
UA (1) | UA90875C2 (ko) |
WO (1) | WO2006074398A2 (ko) |
ZA (1) | ZA200705530B (ko) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4546824B2 (ja) | 2002-05-21 | 2010-09-22 | ギリアード・パロ・アルト・インコーポレイテッド | 糖尿病を処置する方法 |
US8822473B2 (en) * | 2002-05-21 | 2014-09-02 | Gilead Sciences, Inc. | Method of treating diabetes |
CA2678319A1 (en) * | 2007-02-13 | 2008-08-21 | Cv Therapeutics, Inc. | Use of ranolazine for the treatment of coronary microvascular diseases |
CA2678272A1 (en) * | 2007-02-13 | 2008-10-02 | Cv Therapeutics, Inc. | Use of ranolazine for the treatment of cardiovascular diseases |
US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
EP2117550A1 (en) * | 2007-02-13 | 2009-11-18 | CV Therapeutics Inc. | Use of ranolazine for the treatment of non-coronary microvascular diseases |
WO2008116083A1 (en) * | 2007-03-22 | 2008-09-25 | Cv Therapeutics, Inc. | Use of ranolazine for elevated brain-type natriuretic peptide |
EP2139480A1 (en) * | 2007-04-12 | 2010-01-06 | CV Therapeutics Inc. | Ranolazine for enhancing insulin secretion |
US20080299195A1 (en) * | 2007-05-31 | 2008-12-04 | Brent Blackburn | Use of ranolazine for elevated brain-type natriuretic peptide |
BRPI0721741A2 (pt) * | 2007-05-31 | 2013-02-13 | Cv Therapeutics Inc | mÉtodo de tratamento de diabetes |
CN101066253B (zh) * | 2007-06-07 | 2011-01-05 | 北京本草天源药物研究院 | 一种雷诺嗪缓释片 |
US20090012103A1 (en) | 2007-07-05 | 2009-01-08 | Matthew Abelman | Substituted heterocyclic compounds |
WO2009100380A1 (en) * | 2008-02-06 | 2009-08-13 | Cv Therapeutics, Inc. | Use of ranolazine for treating pain |
US20100292217A1 (en) * | 2009-05-14 | 2010-11-18 | Gilead Palo Alto, Inc. | Ranolazine for the treatment of cns disorders |
US8901128B2 (en) | 2009-05-28 | 2014-12-02 | Lupin Limited | Pharmaceutical compositions of ranolazine |
MX2012003362A (es) | 2009-09-25 | 2012-06-27 | Lupin Ltd | Composicion de liberación sostenida de ranolazina. |
TWI508726B (zh) | 2009-12-21 | 2015-11-21 | Gilead Sciences Inc | 治療心房纖維性顫動之方法 |
TW201215392A (en) | 2010-06-16 | 2012-04-16 | Gilead Sciences Inc | Use of ranolazine for treating pulmonary hypertension |
ES2414384T3 (es) | 2011-05-11 | 2013-07-19 | Ratiopharm Gmbh | Composición de liberación modificada que comprende ranolazina |
CN104758265B (zh) * | 2014-01-07 | 2019-05-17 | 四川海思科制药有限公司 | 一种雷诺嗪缓释片药物组合物及其制备方法 |
WO2016144855A1 (en) * | 2015-03-07 | 2016-09-15 | Innophos, Inc. | Leavening composition to replace aluminum based leavening acids |
TW201717919A (zh) | 2015-07-02 | 2017-06-01 | 國際藥品股份公司 | 雷諾多重壓縮錠劑 |
WO2018001582A1 (en) | 2016-06-30 | 2018-01-04 | Interquim, S.A. | Ranolazine multiple compressed tablets |
CN110859843A (zh) * | 2019-12-17 | 2020-03-06 | 卓和药业集团有限公司 | 一种治疗动脉硬化合并心绞痛的药物组合物及制备方法 |
CN111000818A (zh) * | 2020-01-04 | 2020-04-14 | 东莞市东阳光仿制药研发有限公司 | 一种雷诺嗪组合物及其制备方法 |
GR1010345B (el) * | 2021-12-16 | 2022-11-28 | Φαρματεν Α.Β.Ε.Ε., | Δισκια παρατεταμενης αποδεσμευσης που περιλαμβανουν ρανολαζινη και μεθοδος παραγωγης αυτων |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567264A (en) * | 1983-05-18 | 1986-01-28 | Syntex (U.S.A.) Inc. | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
JPS6242918A (ja) * | 1985-08-20 | 1987-02-24 | Kaken Pharmaceut Co Ltd | 持続性製剤 |
AU622254B2 (en) * | 1989-01-03 | 1992-04-02 | Sterling Drug Inc. | Controlled-release, low dose aspirin |
ATE223218T1 (de) * | 1989-06-23 | 2002-09-15 | Syntex Llc | Ranolazin und verwandte piperazine zum schutz der skelettmuskulatur |
US5527545A (en) * | 1989-09-18 | 1996-06-18 | Recordati S.A. Chemical And Pharmaceutical Company | Liquid-suspension controlled-release pharmaceutical composition |
US5209933A (en) * | 1990-01-10 | 1993-05-11 | Syntex (U.S.A.) Inc. | Long acting calcium channel blocker composition |
US5403593A (en) * | 1991-03-04 | 1995-04-04 | Sandoz Ltd. | Melt granulated compositions for preparing sustained release dosage forms |
US5455045A (en) * | 1993-05-13 | 1995-10-03 | Syntex (U.S.A.) Inc. | High dose formulations |
US6083532A (en) * | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
US6479496B1 (en) * | 1998-09-10 | 2002-11-12 | Cv Therapeutics, Inc. | Methods for treating angina with ranolazine |
US6303607B1 (en) * | 1998-09-10 | 2001-10-16 | Cv Therapeutics, Inc. | Method for administering a sustained release ranolanolazine formulation |
US20030220344A1 (en) * | 2002-04-04 | 2003-11-27 | Luiz Belardinelli | Method of treating arrhythmias |
JP4546824B2 (ja) * | 2002-05-21 | 2010-09-22 | ギリアード・パロ・アルト・インコーポレイテッド | 糖尿病を処置する方法 |
-
2006
- 2006-01-05 JP JP2007550511A patent/JP2008526879A/ja active Pending
- 2006-01-05 WO PCT/US2006/000503 patent/WO2006074398A2/en active Application Filing
- 2006-01-05 EP EP06717674A patent/EP1841411A2/en not_active Withdrawn
- 2006-01-05 GE GEAP200610166A patent/GEP20094784B/en unknown
- 2006-01-05 RU RU2007125656/15A patent/RU2384332C2/ru not_active IP Right Cessation
- 2006-01-05 UA UAA200707605A patent/UA90875C2/ru unknown
- 2006-01-05 BR BRPI0606403-5A patent/BRPI0606403A2/pt not_active IP Right Cessation
- 2006-01-05 MX MX2007008162A patent/MX2007008162A/es unknown
- 2006-01-05 KR KR1020077015511A patent/KR20070093988A/ko not_active Application Discontinuation
- 2006-01-05 US US11/326,965 patent/US20060177502A1/en not_active Abandoned
- 2006-01-05 AU AU2006203890A patent/AU2006203890A1/en not_active Abandoned
- 2006-01-05 CN CNA2006800018333A patent/CN101098682A/zh active Pending
- 2006-01-05 CA CA002593593A patent/CA2593593A1/en not_active Abandoned
-
2007
- 2007-07-05 IL IL184460A patent/IL184460A0/en unknown
- 2007-07-06 ZA ZA200705530A patent/ZA200705530B/xx unknown
- 2007-08-03 NO NO20074037A patent/NO20074037L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006074398A2 (en) | 2006-07-13 |
JP2008526879A (ja) | 2008-07-24 |
UA90875C2 (ru) | 2010-06-10 |
IL184460A0 (en) | 2007-10-31 |
WO2006074398A3 (en) | 2007-02-22 |
AU2006203890A1 (en) | 2006-07-13 |
CA2593593A1 (en) | 2006-07-13 |
US20060177502A1 (en) | 2006-08-10 |
ZA200705530B (en) | 2008-10-29 |
KR20070093988A (ko) | 2007-09-19 |
CN101098682A (zh) | 2008-01-02 |
RU2384332C2 (ru) | 2010-03-20 |
BRPI0606403A2 (pt) | 2009-06-23 |
GEP20094784B (en) | 2009-09-25 |
EP1841411A2 (en) | 2007-10-10 |
MX2007008162A (es) | 2007-07-24 |
RU2007125656A (ru) | 2009-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074037L (no) | Farmasoytiske formuleringer med vedvarende frigivelse | |
DK1962873T3 (da) | Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier | |
CY1111729T1 (el) | Υπογλωσσιο επικαλυμμενο δισκιο | |
NO20075628L (no) | Farmasøytiske formuleringer | |
NO20076347L (no) | Nye regimer for orale monofasiske befruktningshindrene midler | |
ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
EA200802008A1 (ru) | Фармацевтические композиции | |
NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
DK1879623T3 (da) | Genterapi til rygmarvssygdomme | |
ITBO20050123A1 (it) | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina | |
RU2398586C3 (ru) | Фармацевтическая композиция | |
DK1957073T3 (da) | Lægemiddel | |
NO20054224D0 (no) | Nye 2-pyridinkarboksamidderivater | |
BRPI0511900A (pt) | composições farmacêuticas | |
DE602005008726D1 (de) | Verwendet | |
ME01459B (me) | Postupak za doziranje medikamenata | |
MA32349B1 (fr) | Antagonistes de la voie hedgehog a base de phtalazines disubstituees | |
TW200738649A (en) | Calcilytic compounds | |
DK1587478T3 (da) | Farmaceutisk sammensætning | |
NO20063293L (no) | Farmasoytiske forbindelser | |
NO20044448L (no) | Nye forbindelser | |
UY30801A1 (es) | Compuestos calciliticos | |
NO20091386L (no) | Fenyloksyanilinderivater | |
ATE438381T1 (de) | Zolpidemtabletten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |